Literature DB >> 6609967

Uptake and nature of the intracellular binding of cyclosporin A in a murine thymoma cell line, BW5147.

M P Merker, M M Merker, R E Handschumacher.   

Abstract

In a survey of malignant cell lines including a variety of leukemias and lymphomas, BW5147, a T lymphoma from the spontaneous virus-associated thymoma in AKR mice, was found to be the most sensitive to growth inhibition by cyclosporin A (Cs A). Inhibition of growth was cell cycle phase-independent and inhibition of macromolecular precursor uptake was relatively nonspecific. Uptake of radiolabeled Cs A by these cells was characterized by two components: one that appeared saturable at low drug concentrations (0.03 to 1.0 microgram/ml), and another that was nonsaturable at higher drug concentrations (1.0 microgram/ml or higher). Most of the drug concentrated by cells (70 to 80%) was located in the cytosol (100,000 X G supernatant of lysed cells). The apparent m.w. of the drug-macromolecule complex was 15,000 to 20,000 as determined by m.w. exclusion columns. This complex could also be formed by adding drug to cytosol prepared from unexposed cells. The low m.w. complex migrated on a preparative isoelectric focusing column to form two peaks with isoelectric points of 6.8 and 8.5. A method was developed to assay for the binding component, and a sequence of m.w. exclusion columns and isoelectric focusing was used to effect partial purification of the Cs A binding component.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609967

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  An endoplasmic reticulum-specific cyclophilin.

Authors:  K W Hasel; J R Glass; M Godbout; J G Sutcliffe
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

2.  Naltrindole inhibits human multiple myeloma cell proliferation in vitro and in a murine xenograft model in vivo.

Authors:  Jyoti Joshi Mundra; Alexandra Terskiy; Richard D Howells
Journal:  J Pharmacol Exp Ther       Date:  2012-04-26       Impact factor: 4.030

3.  FK506: a novel immunosuppressive agent. Characteristics of binding and uptake by human lymphocytes.

Authors:  V Warty; W Diven; E Cadoff; S Todo; T Starzl; A Sanghvi
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

4.  Evidence for a functional receptor for cyclosporin A on the surface of lymphocytes.

Authors:  N A Cacalano; B X Chen; W L Cleveland; B F Erlanger
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

5.  Characterization of cyclosporine A uptake in human erythrocytes.

Authors:  C Reichel; M von Falkenhausen; D Brockmeier; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

6.  Cyclosporine and alpha-difluoromethylornithine exhibit differential effects on colon and pancreatic cancer in vitro.

Authors:  R Saydjari; C M Townsend; S C Barranco; J C Thompson
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

7.  Cyclosporin A induced augmentation of the beta-adrenergic adenylate cyclase response of pig epidermis.

Authors:  N Kato; K M Halprin; J R Taylor; A Ohkawara
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

8.  Distribution of the cyclosporine binding protein cyclophilin in human tissues.

Authors:  B Ryffel; G Woerly; B Greiner; B Haendler; M J Mihatsch; B M Foxwell
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

9.  Differential sensitivity of pancreatic and colon cancer to cyclosporine and alpha-difluoromethylornithine in vivo.

Authors:  R Saydjari; C M Townsend; S C Barranco; J C Thompson
Journal:  Invest New Drugs       Date:  1988-12       Impact factor: 3.850

10.  Chicken cyclophilin A is an inhibitory factor to influenza virus replication.

Authors:  Chongfeng Xu; Shanshan Meng; Xiaoling Liu; Lei Sun; Wenjun Liu
Journal:  Virol J       Date:  2010-12-30       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.